TNFRSF13C - TNF receptor superfamily member 13C Gene
Also Known as BAFFR; CD268; CVID4; BAFF-R; BROMIX; prolixin
Species: Homo sapiens
About TNFRSF13C
This gene has 1 transcript (splice variant), 91 orthologues, 1 paralogue and is associated with 3 phenotypes. Biased expression in spleen (RPKM 19.7), lymph node (RPKM 17.1) and 5 other tissues.
Summary
B cell-activating factor (BAFF) enhances B-cell survival in vitro and is a regulator of the peripheral B-cell population. Overexpression of Baff in mice results in mature B-cell hyperplasia and symptoms of systemic lupus erythematosus (SLE). Also, some SLE patients have increased levels of BAFF in serum. Therefore, it has been proposed that abnormally high levels of BAFF may contribute to the pathogenesis of autoimmune diseases by enhancing the survival of autoreactive B cells. The protein encoded by this gene is a receptor for BAFF and is a type III transmembrane protein containing a single extracellular cysteine-rich domain. It is thought that this receptor is the principal receptor required for BAFF-mediated mature B-cell survival. [provided by RefSeq, Jul 2008]
TNFRSF13C Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_052945.4 | NP_443177.1 | tumor necrosis factor receptor superfamily member 13C |
TNFRSF13C Protein Structure
BaffR-Tall_bind: BAFF-R, TALL-1 binding (16 - 46)
- 0
- 100
- 184 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
tumor necrosis factor receptor superfamily member 13C |
|
Recombinant TNFRSF13C Proteins
| Cat. No. | Product Name | Accession | Purity |
|---|---|---|---|
| HY-P7130 | BAFFR/TNFRSF13C Protein, Human | Q96RJ3-1 (M1-G76) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P72764 | BAFFR/TNFRSF13C Protein, Human (HEK293, His) | Q96RJ3-1 (S7-A71) | ≥ 95%, as determined by reducing SDS-PAGE. |
| HY-P78065 | BAFFR/TNFRSF13C Protein, Human (Biotinylated, HEK293, His-Avi) | Q96RJ3-1 (S7-A71) | ≥ 95%, as determined by Bis-Tris PAGE. |
| HY-P700453 | BAFFR/TNFRSF13C Protein, Human (HEK293, hFc-Flag) | Q96RJ3-1 (S7-A71) | ≥ 95%, as determined by reducing SDS-PAGE. |
TNFRSF13C Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P81611 | BAFFR Antibody (YA1356) | FC, ELISA | Human |
| HY-P84740 | BAFFR Antibody (YA4437) | WB, FC, ELISA | Human, Rat |
| HY-P84740A | BAFFR Antibody (YA4437)(PBS only) | WB, FC, ELISA | Human, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Immunodeficiency, Common Variable, 4 |
|
|
| Common Variable Immunodeficiency |
|
|
| Immunodeficiency, Common Variable, 2 |
|
|
| Primary Agammaglobulinemia |
|
|
| Lupus Erythematosus |
|
|
| Autoimmune Disease |
|
|
| Systemic Lupus Erythematosus |
|
|
| Follicular Lymphoma |
|
|
| Macroglobulinemia |
|
|
| Transient Hypogammaglobulinemia Of Infancy |
|
|
| B-Cell Lymphoma |
|
|
| Cd40 Ligand Deficiency |
|
|
| Transient Hypogammaglobulinemia |
|
|
| Trypanosomiasis |
|
|
| B Cell Deficiency |
|
|
| Selective Igg Deficiency Disease |
|
|
| Lymphoma, Non-Hodgkin, Familial |
|
|
| Immunodeficiency With Hyper-Igm, Type 4 |
|
|
| Multiple Sclerosis |
|
|
| Immunoglobulin Alpha Deficiency |
|
|
| Potocki-Shaffer Syndrome |
|
|
| Immunodeficiency With Hyper-Igm, Type 3 |
|
|
| Immunodeficiency With Hyper-Igm, Type 1 |
|
|
| Good Syndrome |
|
|
| Rheumatoid Arthritis |
|
|
| Lymphoid Interstitial Pneumonia |
|
|
| Autoimmune Disease Of Exocrine System |
|
|
| Leukemia, Chronic Lymphocytic |
|
|
| Lymphoma, Mucosa-Associated Lymphoid Type |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | TNFRSF13C | VGNC | VGNC:54377 |
| Felis catus | TNFRSF13C | VGNC | VGNC:66405 |
| Bos taurus | TNFRSF13C | VGNC | VGNC:57365 |
| Macaca mulatta | TNFRSF13C | VGNC | VGNC:108067 |
| Mus musculus | TNFRSF13C | MGD | MGI:1919299 |
| Rattus norvegicus | TNFRSF13C | RGD | RGD:1560810 |
| Others | TNFRSF13C | NCBI |